Medroute Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.30 Cr
- Revenue Growth -0.75%
- Profit Growth -26.91%
- Ebitda 1.25%
- Net Worth 9.84%
- Total Assets 43.59%
About Medroute Pharmaceuticals
Medroute Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 August 2014 and has a history of Ten years and five months. Its registered office is in Hoshiarpur, Punjab, India.
The Corporate was formerly known as Med Route India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.30 Cr.
The Key Managerial Personnel (KMP) at Medroute Pharmaceuticals Private Limited India is Shrikanta Naik as CEO. Rita Jain, Sneha Jain, and Varun Jain serve as directors at the Company.
Company Details
-
Location
Hoshiarpur, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900PB2014PTC038855
-
Company No.
038855
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Aug 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Medroute Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shrikanta Naik | CEO | 02-May-2020 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rita Jain
|
Director | 22-Aug-2014 | Current |
|
Sneha Jain
|
Director | 22-Aug-2014 | Current |
|
Varun Jain
|
Director | 22-Aug-2014 | Current |
Financial Performance of Medroute Pharmaceuticals.
Medroute Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.75% decrease. The company also saw a substantial fall in profitability, with a 26.91% decrease in profit. The company's net worth moved up by a moderate rise of 9.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medroute Pharmaceuticals?
In 2023, Medroute Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nexpet India Private LimitedSneha Jain and Varun Jain are mutual person
Charges (Loans)
₹13.01 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.70 Cr
- Others : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2024 | Others | ₹6.00 M | Open |
| 11 Nov 2022 | Hdfc Bank Limited | ₹7.01 M | Open |
How Many Employees Work at Medroute Pharmaceuticals?
Unlock and access historical data on people associated with Medroute Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medroute Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medroute Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
